By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nucleic acids provider Integrated DNA Technologies said today that it has received a Phase II Small Business Innovation Research grant to continue developing a gene silencing technology project it is developing with a start-up firm called SilaGene.

The new technology uses U1 adapters to down-regulate gene expression at the pre-mRNA stage, which could be used as a method of gene silencing in potential therapeutic technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.